Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Bicycle Therapeutics' Receivables - Net history spans 7 years, with the latest figure at $136000.0 for Q1 2025.

  • For Q1 2025, Receivables - Net changed N/A year-over-year to $136000.0; the TTM value through Mar 2025 reached $136000.0, changed N/A, while the annual FY2022 figure was $2.0 million, 104.5% up from the prior year.
  • Receivables - Net reached $136000.0 in Q1 2025 per BCYC's latest filing, down from $233000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $50.0 million in Q1 2023 to a low of $136000.0 in Q1 2025.
  • Average Receivables - Net over 5 years is $12.5 million, with a median of $2.0 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: soared 2073.91% in 2023, then crashed 99.48% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $1.0 million in 2021, then soared by 104.5% to $2.0 million in 2022, then skyrocketed by 2104.89% to $45.1 million in 2023, then plummeted by 99.48% to $233000.0 in 2024, then tumbled by 41.63% to $136000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Receivables - Net are $136000.0 (Q1 2025), $233000.0 (Q2 2024), and $45.1 million (Q2 2023).